ArticleAIDS (London, England)2011

First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.

Andrea L Ciaranello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.